Myriad Genetics
MYGN
#6699
Rank
C$0.91 B
Marketcap
C$9.79
Share price
-0.28%
Change (1 day)
-53.48%
Change (1 year)

Myriad Genetics (MYGN) - Total assets

Total assets on the balance sheet as of September 2025 : C$1.00 Billion

According to Myriad Genetics's latest financial reports the company's total assets are C$1.00 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Myriad Genetics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$1.47 B-3.03%
2023-12-31C$1.52 B-6.51%
2022-12-31C$1.62 B-3.36%
2021-12-31C$1.68 B
2020-06-30C$1.90 B-6.8%
2019-06-30C$2.04 B32.36%
2018-06-30C$1.54 B-1.59%
2017-06-30C$1.57 B37.64%
2016-06-30C$1.14 B19.35%
2015-06-30C$0.95 B8.75%
2014-06-30C$0.87 B4.02%
2013-06-30C$0.84 B20.18%
2012-06-30C$0.70 B19.45%
2011-06-30C$0.58 B-6.36%
2010-06-30C$0.62 B17.32%
2009-06-30C$0.53 B5.35%
2008-06-30C$0.50 B27.78%
2007-06-30C$0.39 B29.62%
2006-06-30C$0.30 B55.63%
2005-06-30C$0.19 B-21.32%
2004-06-30C$0.25 B1.85%
2003-06-30C$0.24 B3.22%
2002-06-30C$0.23 B-8.51%
2001-06-30C$0.26 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Bio-Rad Laboratories
BIO
C$13.43 B 1,231.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
C$8.17 B 710.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C$30.61 M-96.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$10.54 B 945.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$116.60 B 11,461.74%๐Ÿ‡บ๐Ÿ‡ธ USA